Clinical Trials Directory

Trials / Completed

CompletedNCT00570739

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

Effects of Metformin HCl in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, as Initial Therapy in Drug naïve Subjects With Type 2 Diabetes Mellitus, and the Effects of Colesevelam HCl on the Lipid Profile in Subjects With Pre Diabetes

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
502 (actual)
Sponsor
Daiichi Sankyo · Industry
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Not accepted

Summary

This is a 16-week double-blind, placebo-controlled (for colesevelam hydrochloride (HCl)) study in the type 2 diabetic subjects and pre-diabetic subjects. Diabetic participants will also be treated with open label, background,metformin HCl. Two-hundred sixty subjects with type 2 diabetes (T2DM) and 200 pre-diabetic subjects are planned to be be enrolled. Qualified subjects with T2DM will be randomized 1:1 to receive metformin HCl plus colesevelam HCl or metformin HCl plus placebo matching colesevelam HCl. Qualified pre-diabetic subjects will be randomized 1:1 to receive colesevelam HCl or matching placebo.

Conditions

Interventions

TypeNameDescription
DRUGMetformin HCl and Colesevelam PlaceboOne or two Metformin HCl tablets 850 mg (depending on tolerability) and 6 colesevelam 625 mg placebo tablets once daily for 16 weeks
DRUGMetformin HCl tablets and Colesevelam tabletsOne or two Metformin HCl tablets 850 mg (depending on tolerability) and 6 colesevelam 625 mg tablets once daily for 16 weeks
DRUGColesevelam placeboSix colesevelam 625 mg placebo tablets will be given once a day for 16 weeks
DRUGColesevelamSix colesevelam 625 mg tablets will be given once a day for 16 weeks.

Timeline

Start date
2007-11-01
Primary completion
2009-04-01
Completion
2009-05-01
First posted
2007-12-11
Last updated
2010-07-27
Results posted
2010-07-13

Locations

31 sites across 4 countries: United States, Colombia, India, Mexico

Source: ClinicalTrials.gov record NCT00570739. Inclusion in this directory is not an endorsement.